!""#"$%#& - PowerPoint PPT Presentation

!""#"$%#& *+,-,.&,/(01&-+*2&,*0345*6&780&9:08+*(2&'(;*216& '()*&%&

From strategies to services � – eHealth as the enabler for cross- border healthcare �

From Strategies to Services � Provide concrete cross border services that ensure safe, secure and • ! efficient medical treatment for citizens when travelling across Europe � Focus on services close to the patient: � • ! – ! Patient Summary for EU Citizens � • ! Occasional Visit � • ! Regular Visit � – ! ePrescribing for EU Citizens � • ! Medication Re-dispense � • ! Medication Occasional Dispense � Build on existing National eHealth Projects and use experiences and • ! knowledge from all Member States �

Closer Cooperation on Healthcare � • ! Healthcare a strict national prerogative � • ! Previously only limited co-operation on a general policy level � • ! Substantial variations between national healthcare systems, but also similar challenges are faced and…. � • ! …substantial similarities in political ambitions to reform healthcare as well as in the challenges to reach these goals � • ! The work started in 2003-2006 at the Ministerial Conferences � • ! In 2004 the eHealth Action Plan was adopted and the I2010 was created � • ! And in 2007 in Berlin the eHealth Initiative was created.… �

2008 a New Era � a new era in legal and policy framework for EU Cooperation on eHealth � • ! Proposal for a European Directive on patients’ rights in cross- border healthcare � • ! Commission Recommendation on cross-border interoperability of electronic health record systems � • ! Communication on telemedicine for the benefit of patients, healthcare systems and society � • ! eHealth Standardisation Mandate 403 �

Goals & Challenges � • ! Goal for the epSOS eHealth Project: � – ! “ to develop a practical eHealth framework and ICT infrastructure that will enable secure access to patient health information, particularly with respect to a basic patient summary and ePrescription, between European healthcare systems” � • ! Challenges to get there: � – ! Legal Interoperability � – ! Organisational Interoperability � – ! Semantic Interoperability � – ! Technical Interoperability �

The Pilot Team � <=*&'08>*51&<*(/&58264616&87&!?&@*2*A54(04*6&708/&%!& /*/@*0&61(1*6B& !"#$%&#$'(#$')#$(*#$(+#$,-#$."#$/*#$+)#$ +($012$345$6)$ & – ! #&C(;82(D&E4246104*6&87&F*(D1=G%H&C(;82(DI 0*)482(D&J8/+*1*25*&J*21*06K& $ – ! J8/+*1*25*&J*21*06&L25D:M42)IN80O42)&N41=&D85(D& 80)(24P(;826&N41=&1=8:6(2M6&87&J82104@:1806& – ! LF9.9:08+*&0*+0*6*2;2)&LJ<&42M:610Q&1*(/&

The Industry team � 78$ .1=A153$$ !99513:;5$$ .1EC5?$$ !<=0$>50?34%0;5$$ .135?$%A;@A;0DA1$+M!M$$ !@A??A$ *AFI0;2C0$.1=A;F0D90$$ B;CDE4$"5?59AF$$ 8C9;AEAN$$ %CE9A$$ /53EF0;3$$ %8G$852C90$$ O;09?5$$ %:E3A2CH$$ GAE0F$$ 2I8ADA1$$ -.+($$ '520?:E$$ +C15:;0$+@!$$ (?593;A1C9$-59A;2$%AF@01J$$ +F0;3.+$$ (".!8$$ +35;C0$8:FF5;3$%A1E:?D1<$!K$$ K($>50?3490;5$$ "C01CP+@C;C3$$ K1AFA1$$ ";5I?58$ .%L$$ "P+JE35FE$ .12;0$ QP351DA1$

Availability of Patient identifier 2008 � Single (national) patient identifier Multiple (regional) patient identifiers EU memberstate (not participating) Non EU country

Availability of Patient Identifier 2010 � Single (national) patient identifier Multiple (regional) patient identifiers EU memberstate (not participating) Non EU country

HCP/HCPO Identifier – Suitability for Authentication & Digital signing 2008 � Nationally-led Fully available Partly available Regionally-led Fully available Partly available Not available / unknown EU memberstate (not participating) Non EU country

HCP/HCPO Identifier – Suitability for Authentication & Digital signing 2010 � Nationally-led Fully available Partly available Regionally-led Fully available Partly available Not available / unknown EU memberstate (not participating) Non EU country

Availability of opt-out Consent 2008 � Nationally-led Fully available Partly available Regionally-led Fully available Partly available Not available / unknown EU memberstate (not participating) Non EU country

Availability of opt-out consent 2010 � Nationally-led Fully available Partly available Regionally-led Fully available Partly available Not available / unknown Opt-out likely to be implemented EU memberstate (not participating) Non EU country

Availability of Patient Summary 2008 � >25% Nationally available & operational <25% >25% Regionally available & operational <25% Not available / unknown EU memberstate (not participating) Non EU country

Availability of Patient Summary 2010 � >25% Nationally available & operational <25% >25% Regionally available & operational <25% Not available / unknown EU memberstate (not participating) Non EU country

Availability of ePrescriptions 2008 � >25% Nationally available & operational <25% >25% Regionally available & operational <25% Not available / unknown EU memberstate (not participating) Non EU country

Availability of ePrescriptions 2010 � >25% Nationally available & operational <25% >25% Regionally available & operational <25% Not available / unknown EU memberstate (not participating) Non EU country

Availability of Dispense Information 2008 � >25% Nationally available & operational <25% >25% Regionally available & operational <25% Not available / unknown EU memberstate (not participating) Non EU country

Availability of Dispense Information 2010 � >25% Nationally available & operational <25% >25% Regionally available & operational <25% Not available / unknown EU memberstate (not participating) Non EU country

Availability of Medication Summary 2008 � >25% Nationally available & operational <25% >25% Regionally available & operational <25% Not available / unknown EU memberstate (not participating) Non EU country

Availability of Medication Summary 2010 � >25% Nationally available & operational <25% >25% Regionally available & operational <25% Not available / unknown EU memberstate (not participating) Non EU country

Legal Interoperability � LC34A:3$0R5F@D1<$3A$C135;S515$C1$345$ 5HCED1<$$8+$?5<0?$=;0F5TA;UEM$!1$ V5@+O+$?5<0?$C135;A@5;0IC?C3J$?0J5;W$ CE$9;50352M$ XM ! @;ASCECA1E$=A;$022;5EEC1<$0??$ 5EE51D0?$*Y-$;5Z:C;5F513E$A=$ 8+$0E$@0;3$A=$345$25EC<1$[$$ \M ! E:94$@;ASCECA1E$0;5$3;01E?0352$ C13A$EJE35F$012$E5;SC95$ E@59C]90DA1E$^E0=5<:0;2E_$ 7M ! !@@?C90DA1$A=$E0=5<:0;2E$CE$ 0:2C30I?5$`$)5J$-A?5$A=$/%GE $

Legal Issues: Summary of findings � 80C1$.EE:5E$ *5<0?$ 5@+O+$ 80C1$%40??51<5$ (H@59352$.F@093$ %5;30C13J$ !@@;A094$ '030$G;A359DA1$ +:a9C513$ =525;0D1<$ (6$?5S5?$.1=A;F0DA1$ 3AT0;2E$ 10DA10?$3;:E3$ KAS5;10195$ 40;FA1Cb0DA1$A=$ 012$%A1]251D0?C3J$ EJE35FE$ @;09D95$ >50?34$+JE35FE$ *AT$ 5@+O+$ E59:;5$9A??0IA;0DA1$ "AT0;2E$0995?5;0D1<$ @A?C9C5E$012$ TC34$?A90?$0:34A;CD5E$ 345$25@?AJF513$A=$ E0=5<:0;2E$ ;5CFI:;E0I?5$5>50?34$ 9;AEE$IA;25;$E5;SC95E$ G;A=5EECA10?$ *AT$ 9A:13;J$A=$ (H@?A;5$@;A=5EECA10?$ "AT0;2E$?5<0?$ 3;503F513$ ;C<43E$C1$345$9A135H3$A=$ 95;30C13J$A1$ 0E@593E$012$EA9C0?$ ;:?5E$0@@?J$ 9;AEE$IA;25;$90;5$ @;A=5EECA10?E$;C<43E$C1$ 9A135H3$$ 345$I;A025;$9A135H3$ 5M<M$$35?5F52C9C15$ *C0IC?C3J$ *AT$ 5?0IA;0DA1$ 9A??0IA;0DA1$TC34$(6$ "AT0;2E$F:3:0?$ A=$E@59C]9$ ?5S5?$@;A=5EECA10?$ ;59A<1CDA1$ E0=5<:0;2E$$ 0EEA9C0DA1E#$012$ E30U54A?25;E$

Where are we at? � <=*&R*D43*0*M& – ! L24;(D&,58+*& – ! S*)(D&T&U*):D(180Q&J82610(4216& – ! U*+801&82&-++801:24;*6&(2M&J82610(4216&87&+(0;54+(;2)&E,& – ! R466*/42(;82&J825*+1&(2M&'D(2& – ! 93(D:(;82&E*1=8M8D8)Q&(2M&'D(2& – ! U*346*M&'08>*51&'D(2& – ! R0(V&R*A24;82&87&8+*0(;82(D&,*0345*&U*W:40*/*216.& *'0*6504+;82& – ! R0(V&R*A24;82&87&8+*0(;82(D&,*0345*&U*W:40*/*216&X& '(;*21&,://(0Q&

What is next? � <=*&R*D43*0(@D*6&18&@*&R*D43*0*M&(1&1=*&*2M&87&1=*&Q*(0&18&1=*& J8//466482 $ & – ! ,*5:041Q&6*0345*6&6+*54A5(;82&M*A24;82& – ! LM*2;1Q&/(2()*/*21&6*0345*6&6+*54A5(;82&M*A24;82& – ! R0(V&*+,-,&6Q61*/&1*5=245(D&6+*54A5(;82& – ! ,*/(2;5&,*0345*6&M*A24;82& – ! J8//82&J8/+82*216&,+*54A5(;82& – ! <*61&,5*2(0486&(2M&,41*&J=845*& – ! R0(V&C(;82(D&'4D81&,*1:+&(2M&R*+D8Q/*21&):4M*& – ! L21*08+*0(@4D41Q&70(/*N80O& – ! ,1(2M(0M&J8210(516&1*0/6&780&E,&M85:/*21&780&*2)()*/*21& 87&+4D816&

Overall Project Plan � - ! Asking for approval of D5.2.2 Revised Project plan: � - ! Conclusion after analysis and re-planning: Extension of project duration by 6 months �